Skip to content

Biz News Today

Business News – Direct Source News

  • Home
  • Business News Videos
    • International/National News Videos
  • Directory
  • Links PRs
  • REITS
  • About
  • Contact
    • Sitemap

Bristol Myers Squibb Announces Data from EXPLORER-LTE Demonstrating Sustained Improvements in Clinically Meaningful Cardiovascular Outcomes at Weeks 48 and 84 in Patients with Symptomatic Obstructive Hypertrophic Cardiomyopathy Receiving Mavacamten

  • Home
  • 2022
  • April
  • 3
  • Bristol Myers Squibb Announces Data from EXPLORER-LTE Demonstrating Sustained Improvements in Clinically Meaningful Cardiovascular Outcomes at Weeks 48 and 84 in Patients with Symptomatic Obstructive Hypertrophic Cardiomyopathy Receiving Mavacamten

Original Source

On April 3, 2022

Post navigation

Previous PostMavacamten Demonstrated Significant Reduction in Need for Septal Reduction Therapy in Symptomatic Obstructive HCM Patients in Phase 3 VALOR Trial
Next PostHII Launches National Security Cutter Calhoun (WMSL 759)

Related Post

May 20, 2022
  • Business News

Duke Energy offers tips, tools to help customers save energy, money as temperatures rise

May 20, 2022
  • Business News

S&P Colombia Select Index Consultation on Eligibility Criteria and Index Construction

May 20, 2022
  • Business News

S&P Equal Sector ESG Select Equal Weight Indices Methodology

Copyright © All right reserved
Newslist Created By Rise Themes

Notice: ob_end_flush(): failed to send buffer of zlib output compression (0) in /home/biznews/public_html/wp-includes/functions.php on line 5219